PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-7.48%
Revenue decline while 3088.T shows 8.07% growth. Joel Greenblatt would examine competitive position erosion.
-7.48%
Cost reduction while 3088.T shows 6.55% growth. Joel Greenblatt would examine competitive advantage.
-7.46%
Gross profit decline while 3088.T shows 11.28% growth. Joel Greenblatt would examine competitive position.
0.02%
Margin expansion below 50% of 3088.T's 2.98%. Michael Burry would check for structural issues.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
13.77%
Similar other expenses growth to 3088.T's 14.29%. Walter Schloss would investigate industry patterns.
0.60%
Operating expenses growth less than half of 3088.T's 4.08%. David Dodd would verify sustainability.
-6.23%
Total costs reduction while 3088.T shows 5.83% growth. Joel Greenblatt would examine advantage.
6.67%
Interest expense change of 6.67% while 3088.T maintains costs. Bruce Berkowitz would investigate control.
-0.99%
D&A reduction while 3088.T shows 0.25% growth. Joel Greenblatt would examine efficiency.
-18.56%
EBITDA decline while 3088.T shows 41.13% growth. Joel Greenblatt would examine position.
-11.98%
EBITDA margin decline while 3088.T shows 30.60% growth. Joel Greenblatt would examine position.
-28.32%
Operating income decline while 3088.T shows 58.44% growth. Joel Greenblatt would examine position.
-22.53%
Operating margin decline while 3088.T shows 46.61% growth. Joel Greenblatt would examine position.
83.23%
Other expenses growth while 3088.T reduces costs. John Neff would investigate differences.
-24.99%
Pre-tax income decline while 3088.T shows 58.05% growth. Joel Greenblatt would examine position.
-18.93%
Pre-tax margin decline while 3088.T shows 46.25% growth. Joel Greenblatt would examine position.
-23.91%
Tax expense reduction while 3088.T shows 73.10% growth. Joel Greenblatt would examine advantage.
-25.47%
Net income decline while 3088.T shows 51.01% growth. Joel Greenblatt would examine position.
-19.45%
Net margin decline while 3088.T shows 39.73% growth. Joel Greenblatt would examine position.
-25.47%
EPS decline while 3088.T shows 53.44% growth. Joel Greenblatt would examine position.
-25.47%
Diluted EPS decline while 3088.T shows 53.53% growth. Joel Greenblatt would examine position.
-0.00%
Share count reduction while 3088.T shows 0.00% change. Joel Greenblatt would examine strategy.
-0.00%
Diluted share reduction while 3088.T shows 0.00% change. Joel Greenblatt would examine strategy.